跳到正文
cccskills
免费在 GitHub 公开

esa-pa-skip-confirmatory-testing

This skill determines whether confirmatory testing can be omitted after a positive aldosterone-to-renin ratio (ARR) in patients with suspected primary aldosteronism. It is applied when a patient exhibits spontaneous hypokalemia, undetectable renin, and a plasma aldosterone concentration ≥20 ng/dL (550 pmol/L).

中文简介正在准备中。当前显示原文说明。

查看安装方法

包含的文件(1)

  • SKILL.md2.6 KB

SKILL.md(原文)

安装前可以查看交给 AI 代理的指令内容。

Determine When to Skip Confirmatory Testing for PA

STEP 1 — Gather Information

Confirm a positive ARR; assess serum potassium for spontaneous hypokalemia (K⁺ <3.5 mmol/L without diuretic cause); measure plasma renin activity (or direct renin concentration) to verify undetectable levels (< assay detection limit); obtain plasma aldosterone concentration (PAC).

STEP 2 — Rule In / Rule Out

Is the patient spontaneously hypokalemic AND renin undetectable AND PAC ≥20 ng/dL (550 pmol/L)?

  • Yes → proceed to Step 3 (skip confirmatory testing).
  • No → proceed to Step 3 (perform confirmatory testing).

STEP 3 — Classify or Stratify

If criteria met: classify as high‑confidence PA (can move directly to subtype testing).
If criteria not met: classify as indeterminate PA (requires confirmatory testing to confirm/exclude diagnosis).

STEP 4 — Decide

  • For high‑confidence PA: skip confirmatory testing; advance to adrenal CT for subtype evaluation.
  • For indeterminate PA: perform a confirmatory test (e.g., saline infusion test, fludrocortisone suppression test, captopril challenge test, or furosemide upright test) per guideline recommendations.

Clinical Guardrails / Mimics / Pitfalls

Do not mislabel diuretic‑induced hypokalemia as spontaneous; ensure renin assay sensitivity is adequate to detect low levels. Avoid skipping confirmatory testing in patients with severe uncontrolled hypertension, renal insufficiency, or recent mineralocorticoid receptor antagonist use without adequate washout, as these increase false‑positive risk. Remember that skipping testing raises the chance of misdiagnosing bilateral adrenal hyperplasia as unilateral disease.

Concrete Clinical Example

A 48‑year‑old hypertensive patient presents with spontaneous hypokalemia (K⁺ 3.0 mmol/L), undetectable renin (<0.1 ng/mL/h), PAC 24 ng/dL, and a positive ARR. Criteria are met, so confirmatory testing is skipped; the patient proceeds directly to adrenal CT, which shows a 1.2 cm left adrenal nodule, leading to laparoscopic adrenalectomy.

Source: The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2016, DOI:10.1210/jc.2015-4061

评价

还没有评价。欢迎分享你的使用感受。

评论

无需登录即可发表。欢迎分享使用感受、提问,或说明在哪些环境下无法运行。

还没有评论。来写第一条吧。

提交后会立即公开。请勿填写邮箱、电话等个人信息。URL 最多 2 个。

0 / 1000 字

此表单受 reCAPTCHA 保护,适用 Google 的隐私权政策和服务条款。

同一仓库的技能

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

中文简介正在准备中。当前显示原文说明。

dromlakhani/MD2SKILL142026年10月20日 更新

查看 dromlakhani 的全部技能

报告此技能的问题